2. 2 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Highlights
In 2021, IDF estimates show that:
1 in 2
Adults is undiagnosed
240 million people
9%
Of global health expenditure spent
on diabetes (USD 966 billion)
1 in 10
Adults (20-79 years)
has diabetes
537 million people
1 in 6
Live births (21 million) affected
by hyperglycaemia in pregnancy,
80% have mothers with GDM
6.7 million
Deaths attributed to diabetes
1 in 18
Adults (20-79 years) has
impaired fasting glucose
319 million people
1 in 9
Adults (20-79 years) has
impaired glucose tolerance
541 million people
1.2 million
Children and adolescents below
20 years have type 1 diabetes
3 in 4
People with diabetes live in
low and middle-income countries
3. 3 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Highlights
In 2021, IDF estimates show that:
7.8 million
More adults with diabetes
undiagnosed
1.67 million
More adults with impaired
glucose tolerance
US$206 billion
More USD spent on diabetes
700,000
More pregnancies affected
by hyperglycaemia
2.5 million
More deaths caused by diabetes
149,500
More children and adolescents
with type 1 diabetes
73.6 million
More adults with diabetes
4. 4 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
All editions of the IDF Diabetes Atlas
2000-2021
First edition, 2000
Second edition,
2003
Third edition, 2006 Fourth edition, 2009 Fifth edition, 2011
Sixth edition, 2013 Seventh edition, 2015 Eight edition, 2017 Ninth edition, 2019 Tenth edition, 2021
5. 5 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Number of people with diabetes
Aged 20–79 years by IDF region
6. 6 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Estimates and projections
Global number of adults (20–79 years) in millions
7. 7 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Number of adults with diabetes
Aged 20–79 years, 2021
8. 8 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Prevalence of diabetes
By age and income group (%), 2021
9. 9 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Estimated age-adjusted comparative prevalence of diabetes
In adults aged 20–79 years in 2021
10. 10 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Number of people with diabetes
In adults aged 20–79 years living in urban and rural areas in 2021 and 2045
11. 11 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Top 10 countries with diabetes
In adults aged 20–79 years and diabetes-related health expenditure, 2021
12. 12 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Number and proportion of adults with undiagnosed diabetes
Aged 20–79 years, per region, 2021
13. 13 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Proportion of adults with undiagnosed diabetes
Aged 20–79 years by country in 2021
14. 14 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Age-sex standardised incidence rates of type 1 diabetes
Per 100,000 population per annum in children and adolescents aged 0–14 years and incidence of
adult-onset type 1 diabetes in adults aged 20–40 years
16. 16 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Hyperglycaemia in pregnancy
Per IDF region, 2021
17. 17 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Number of deaths by sex and age
Aged 20–79 years, 2021
18. 18 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Total diabetes-related health expenditure for adults
Aged 20–79 years with diabetes in USD and ID
19. 19 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Total diabetes-related expenditure and health expenditure
Per person and per income group, 2021
20. 20 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Diabetes-related health expenditure as a percentage
of Gross Domestic Product (GDP)
By IDF region
21. 21 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Limitations
Contact | Website diabetesatlas.org
Our definition of diabetes is based on an epidemiological definition. We therefore require only one abnormal
glucose value, compared to a clinical diagnosis, where abnormal glucose across two tests is required to make a
diagnosis
Raw data is subject to heterogeneity in terms of calendar year, diagnostic method, representativeness and
precision of the study design. While we attempt to address this using analytic hierarchy process, bias may still be
present
For countries without in-country data, diabetes prevalence is extrapolated based on data from a country with
similar demography, economy and language group. This may introduce error
There is a dearth of data from the African region
For our projections, we only consider demographic changes in age, sex and urbanisation. We do not take into
account other factors that may influence diabetes incidence
22. 22 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Summary
Contact | Website diabetesatlas.org
In 2021, the IDF 10 Edition of the Atlas estimates that 1/10 people aged 20-79 have diabetes
This equates to 537 million people in the world
By 2045, this number will increase to 784 million
There still remain gaps in our estimates due to absent and low-quality data in some parts of the
world
There is a strong need for effective intervention strategies and policies to stall the increase in the
number of people developing diabetes
23. 23 | IDF Diabetes Atlas 2021– 10th edition www.idf.org @IntDiabetesFed
Acknowledgements
Contact | Website diabetesatlas.org
IDF Diabetes Atlas, 10th Edition Committee
Dianna J Magliano (Co-chair), Edward J Boyko (Co-chair), Beverley Balkau, Noel Barengo,
Elizabeth Barr, Abdul Basit, Christian Bommer, Gillian Booth, Bertrand Cariou, Juliana Chan,
Hongzhi Chen, Lei Chen, Tawanda Chivese, Dana Dabalea, Hema Divakar, Daisy Duan,
Bruce B Duncan, Michael Fang, Ghazal Fazli, Courtney Fischer, Kathryn Foti, Laercio Franco, Edward
Gregg, Leonor Guariguata, Akhil Gupta, Anthony Hanley, Jessica L Harding,
William H Herman, Cheri Hotu, Cecilia Høgfeldt, Elbert Huang, Adam Hulman, Steven James,
Alicia J Jenkins, Seung Jin Han, Calvin Ke, Emma L Klatman, Shihchen Kuo, Jean Lawrence,
Dinky Levitt, Xia Li, Lorraine Lipscombe, Paz Lopez-Doriga Ruez, Andrea Luk, Ronald C Ma,
Jayanthi Maniam, Louise Maple-Brown, Jean-Claude Mbanya, Natalie McGlynn, Fernando Mijares Diaz,
Hiliary Monteith, Ayesha Motala, Estelle Nobecourt, Graham D Ogle, Katherine Ogurstova, Richard Oram,
Bige Ozkan, Emily Papadimos, Chris Patterson, Meda Pavkov, Cate Pihoker,
Justin Porter, Camille Powe, Ambady Ramachandran, Gojka Roglic, Mary Rooney, Julian Sacre, Elizabeth
Selvin, Baiju Shah, Jonathan E Shaw, David Simmons, Caroline Stein, Jannet Svensson, Olive Tang, Justin
Echouffo Tcheugui, Jincy Varghese, Amelia Wallace, Pandora L Wander,
Donald Warne, Mahmoud Werfalli, Sarah Wild, Jencia Wong, Yuting Xie, Xilin Yang, Lili Yuen,
Philip Zeitler, Ping Zhang, Sui Zhang, Xinge Zhang, Zhiguang Zhou
Editorial team
Edward J Boyko, Dianna J Magliano
Suvi Karuranga, Lorenzo Piemonte, Phil Riley, Pouya Saeedi, Hong Sun
Contributors
Mikkel Pape Dysted, Balázs Esztergályos, Sanju Gautam, Bruno Helman, Moritz Pinkepank, Adilson Randi,
Agus Salim, Katherine Wallis, Beatriz Yáñez Jiménez, Margaux Ysebaert,
GLOBODIAB Research Consortium
Data
The list of studies on which estimates in the IDF Diabetes Atlas
are based, and those considered, but not used, can be found at:
www.diabetesatlas.org
Corporate sponsors
The IDF Diabetes Atlas 10th edition has been produced thanks
to educational grants from Novo Nordisk, Pfizer-MSD Alliance,
and Sanofi.
Editor's Notes
Photography of people living with diabetes in each of IDF’s seven Regions
537 million in 2021 predicted to rise to 784 million in 2045 (a 46% increase)
Our estimations are not without limitations.
Our estimatiInternational collaborators- Too numerous to mention